You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Clinical care process at baseline and follow up (%)

From: Community health workers improve diabetes care in remote Australian Indigenous communities: results of a pragmatic cluster randomized controlled trial

  Baseline Endpoint (excluding 22 loss of follow up)
  Control n = 113 Intervention n = 100 Control n = 107 Intervention n = 84
  No % (95% CI) No % (95% CI) No % (95% CI) No % (95% CI)
GPMP for diabetes % 19 22.2 (13.5-30.9) 28 40.3 (29.2-51.4) 24 29.6 (19.5-39.7) 27 40.3 (28.4-52.2)
Foot check% 50 44.2 (35.0-53.5) 31 31.0 (21.8-40.2) 38 35.5 (26.3-44.7) 26 31.0 (20.9-41.0)
Seen by DM educator % 46 40.7 (31.6-49.9) 52 52.0 (42.1-61.9) 41 38.3 (29.0-47.6) 44 52.4 (41.6-63.2)
Seen by dietician % 22 19.5 (12.1-26.8) 30 30.0 (20.9-39.1) 21 19.6 (12.0-27.2) 37 44.0 (33.3-54.8)
Dentist check % 20 17.7 (10.6-24.8) 13 13.0 (6.3-19.7) 9 8.4 (3.1-13.7) 15 17.9 (9.6-26.5)
ECG check% 37 32.7 (24.0-41.5) 42 42.0 (32.2-51.8) 34 43.9 (34.4-53.4) 35 40.5 (29.8-51.1)
Eye check % 54 47.8 (38.5-57.1) 42 42.0 (32.2-51.8) 56 52.3 (42.8-61.9) 37 44.0 (33.3-54.8)
Smoker % 38 34.5 (25.6-43.5) 34 35.1 (25.5-44.7) 33 31.2 (22.4-40.4) 34 41.5 (30.7-52.2)
Blood glucose self-monitor % 45 40.9 (31.6-50.2) 46 46.0 (36.1-55.9) 63 59.4 (50.0-68.9) 44 52.4 (41.6-63.2)
Taking insulin% 55 48.7 (39.4-58.0) 40 40.0 (30.3-49.7) 47 43.9 (34.4-53.4) 40 47.6 (36.8-58.4)
Dislipidemia % 83 73.5 (65.2-81.7) 84 84.0 (76.7-91.3) 91 85.0 (78.2-91.9) 76 90.5 (84.1-96.8)
Taking lipid lowering medicines% 91 81.3 (73.9-88.6) 77 77.0 (68.7-85.3) 87 82.1 (74.7-89.5) 62 73.8 (64.3-83.3)
Albuminuria and taking ACEi or ARB drugs 46 88.5 (79.6-97.3) 47 88.7 (80.0-97.4) 58 82.9 (73.9-91.8) 51 89.5 (81.4-97.6)
Adherent to all medicines 53 46.9 (37.6-56.2) 55 55.0 (45.1-64.9) 57 53.3 (43.7-62.8) 41 48.8 (38.0-59.6)
Had Fluvax 50 44.2 (35.0-53.5) 66 66.0 (56.6-75.4) 51 47.7 (38.1-57.2) 50 59.5 (48.9-70.2)
  1. The proportion calculated on available records. Taking insulin including having either long-term, medium-term or short-term insulin. Albuminuria defined as ACR > =3.4 mg/mmol; taking lipid lowering medicines including statin, fibrate, and lipase inhibitors.